Companies included in PTH
This is PTH's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–61 of 61.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 27,706,338 | NS | 22.917417% |
| Invesco Private Government Fund | Invesco Private Government Fund | 10,675,159.86 | NS | 8.829121% |
| PRAX | Praxis Precision Medicines, Inc. | 19,267 | NS | 5.080616% |
| ROIV | Roivant Sciences Ltd. | 197,099 | NS | 4.650817% |
| UTHR | United Therapeutics Corp. | 7,268 | NS | 3.434474% |
| THC | Tenet Healthcare Corp. | 20,745 | NS | 3.038954% |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | 65,368 | NS | 2.861608% |
| TNGX | Tango Therapeutics Inc. | 159,490 | NS | 2.851887% |
| HCA | HCA Healthcare, Inc. | 7,728 | NS | 2.776835% |
| AXSM | Axsome Therapeutics, Inc. | 15,385 | NS | 2.643514% |
| NKTR | Nektar Therapeutics | 36,570 | NS | 2.572121% |
| CELC | Celcuity Inc. | 25,182 | NS | 2.527395% |
| IONS | Ionis Pharmaceuticals, Inc. | 38,394 | NS | 2.373973% |
| CAPR | Capricor Therapeutics, Inc. | 81,402 | NS | 2.260783% |
| COR | Cencora, Inc. | 8,829 | NS | 2.249155% |
| ALMS | Alumis Inc. | 103,872 | NS | 2.121108% |
| GILD | Gilead Sciences, Inc. | 18,363 | NS | 1.987135% |
| KOD | Kodiak Sciences Inc. | 55,223 | NS | 1.985878% |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | 49,825 | NS | 1.976788% |
| JAZZ | Jazz Pharmaceuticals PLC | 11,426 | NS | 1.918563% |
| MRNA | Moderna, Inc. | 50,080 | NS | 1.902823% |
| PTGX | Protagonist Therapeutics, Inc. | 23,165 | NS | 1.896177% |
| VTRS | Viatris Inc. | 152,008 | NS | 1.878279% |
| DNTH | Dianthus Therapeutics, Inc. | 24,726 | NS | 1.795525% |
| ANAB | AnaptysBio, Inc. | 32,708 | NS | 1.778119% |
| ENSG | Ensign Group, Inc. (The) | 11,223 | NS | 1.732898% |
| INCY | Incyte Corp. | 21,763 | NS | 1.714818% |
| ERAS | Erasca, Inc. | 194,096 | NS | 1.709658% |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | 8,520 | NS | 1.616854% |
| ORKA | Oruka Therapeutics, Inc. | 28,323 | NS | 1.602514% |
| CGON | CG Oncology, Inc. | 28,115 | NS | 1.551913% |
| TYRA | Tyra Biosciences, Inc. | 53,591 | NS | 1.540245% |
| SLS | SELLAS Life Sciences Group, Inc. | 367,216 | NS | 1.503384% |
| SYRE | Spyre Therapeutics, Inc. | 24,120 | NS | 1.485201% |
| KYMR | Kymera Therapeutics, Inc. | 21,835 | NS | 1.464052% |
| TWST | Twist Bioscience Corp. | 30,064 | NS | 1.453364% |
| LQDA | Liquidia Corp. | 43,673 | NS | 1.416293% |
| BKD | Brookdale Senior Living Inc. | 118,923 | NS | 1.412419% |
| AXGN | Axogen, Inc. | 38,310 | NS | 1.368797% |
| EXEL | Exelixis, Inc. | 36,251 | NS | 1.333007% |
| EWTX | Edgewise Therapeutics, Inc. | 51,209 | NS | 1.311265% |
| TRVI | Trevi Therapeutics, Inc. | 114,114 | NS | 1.298675% |
| CYTK | Cytokinetics, Inc. | 22,459 | NS | 1.188256% |
| ELAN | Elanco Animal Health Inc. | 62,951 | NS | 1.164694% |
| RLAY | Relay Therapeutics, Inc. | 105,574 | NS | 1.131632% |
| DYN | Dyne Therapeutics, Inc. | 77,358 | NS | 1.12286% |
| PCVX | Vaxcyte, Inc. | 23,663 | NS | 1.120244% |
| KRYS | Krystal Biotech, Inc. | 5,073 | NS | 1.100373% |
| ELVN | Enliven Therapeutics, Inc. | 31,343 | NS | 1.068801% |
| RCUS | Arcus Biosciences, Inc. | 44,685 | NS | 0.942421% |
| ANNX | Annexon, Inc. | 188,931 | NS | 0.917243% |
| STOK | Stoke Therapeutics, Inc. | 33,715 | NS | 0.912388% |
| PAHC | Phibro Animal Health Corp. | 20,545 | NS | 0.903644% |
| MLTX | MoonLake Immunotherapeutics | 58,091 | NS | 0.786984% |
| BIOA | BioAge Labs, Inc. | 55,347 | NS | 0.771324% |
| SNDX | Syndax Pharmaceuticals, Inc. | 41,013 | NS | 0.72692% |
| CATX | Perspective Therapeutics Inc. | 207,471 | NS | 0.669214% |
| ZBIO | Zenas Biopharma, Inc. | 39,681 | NS | 0.634064% |
| VRDN | Viridian Therapeutics, Inc. | 52,099 | NS | 0.580848% |
| MAZE | Maze Therapeutics, Inc. | 23,066 | NS | 0.507073% |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 322,235.69 | NS | 0.266512% |
SEC N-PORT snapshot as of .